Given this risk, we thought we'd take a look at whether Dianthus Therapeutics (NASDAQ:DNTH) shareholders should be worried about its cash burn. For the purposes of this article, c ...

Full Year 2024 Results Key Financial Results Net loss: US$85.0m (loss widened ...

Advice from top interior designers (and real-life renovators) on what to do and what not to do when tackling the bathroom ...

Dianthus Therapeutics, Inc. (NASDAQ:DNTH – Get Free Report) has received a consensus recommendation of “Buy” from the nine ...

Retail Opportunity Investments Corp. (NASDAQ:ROIC – Get Free Report) has been assigned an average recommendation of “Reduce” ...

Dianthus Therapeutics, Inc. (DNTH) came out with a quarterly loss of $0.81 per share versus the Zacks Consensus Estimate of a loss of $0.85. This compares to loss of $0.71 per share a year ago. These ...

Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25Phase 3 CAPTIVATE trial of ...

Reports Q4 revenue $1.33M, consensus $859,700. “We remain on track to report top-line data in 2H’25 from our Phase 2 clinical trial of DNTH103 ...

LEXINGTON, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company ...

Have you also wished to have a wonderful smelling garden? Then you're gonna wanna try planting these colorful and beautiful ...

If your garden is looking bare and lifeless, one gardening expert has shared the best flowers to plant this spring.